Novartis Ups Sales Forecast Driven by Strong Demand for Cancer and Inflammatory Drugs

In a significant enhancement to its financial outlook, Novartis has raised its sales guidance, attributing this upward revision to robust demand for its cancer and inflammatory condition treatments. The global healthcare company announced that it expects an increase in sales growth for 2024, increasing from its previous estimates amid promising results from its advanced therapeutic offerings.

Continue reading

Novartis Raises Profit Forecast Amid Surge in New Drug Sales

In a striking boost to its financial outlook, Swiss pharmaceutical giant Novartis has revised its profit forecast for the year, attributing this positive change to the remarkable sales performance of its newly launched medications. As the pharmaceutical landscape undergoes rapid transformations, Novartis is capitalizing on its innovative pipeline, which is spearheading the company’s drive for growth.

Continue reading